PPARA and transient ischemic attack: Collino et al. also reported that the PPARα agonist WY14643 can significantly depress cerebral oxidative stress and inflammatory responses induced by transient cerebral ischemia reperfusion and that the effect of WY14643 can be abolished by the administration of MK886 (an antagonist of PPARα) [9].